Skip to main content
. 2018 May 10;8:7447. doi: 10.1038/s41598-018-25720-1

Table 2.

ODN inhibition of the HIV-1 IN LEDGF/p75-independent activity.

Compound aIC50 IN LEDGF-independent integration (µM)
INTB-H2 0.145 ± 0.005
INTB-H5 0.150 ± 0.030
INTB-H9 0.178 ± 0.002
INTB-H13 0.225 ± 0.005
INTB-H17 0.225 ± 0.045
INTB-nat 0.270 ± 0.020
Raltegravir 0.058 ± 0.010

aCompound concentration required to inhibit the HIV-1 IN catalytic activities, in the absence of LEDGF, by 50%. Raltegravir has been used as a reference. See main text for details.